MarketPulse

weight management

3 articles
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Three Pharma Giants Poised for Growth: Lilly, Vertex, Pfizer Lead March 2026 Rally

Eli Lilly dominates weight management, Vertex controls cystic fibrosis, and Pfizer offers undervalued shares with 6.3% dividend yield.
PFELLYVRTXdividend yieldcystic fibrosis
GlobeNewswire Inc.GlobeNewswire Inc.··Zealand Pharma

Zealand Pharma's Petrelintide Shows Promise in Obesity Drug Race

Zealand Pharma reports positive Phase 2 data for petrelintide, achieving 10.7% weight loss versus 1.7% placebo with favorable safety profile.
RHHBYZLDPYobesityweight management
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

GLP-1 Therapeutics Market Poised to Exceed $33B by 2030 on Formulation Innovation

GLP-1 therapeutics market projected to grow from $22B in 2025 to $33B by 2030, driven by formulation innovations like oral and extended-release therapies improving accessibility.
PFELLYNVOAZNpersonalized medicinediabetes treatment